Conversio Health key facts
- Provider of pharmacotherapy management services intended to identify and overcome the challenges to optimal outcomes.
- It has raised $39.0M across 2 recorded rounds; the latest was Early Stage VC ($20.3M) in Jan 2024.
- Notable investors include First Trust Capital Partners, HITLAB Innovators, Healthcare Growth Partners, Heritage Group (US).
- Conversio Health has filed 4 Form Ds with the SEC since 2020, most recently Nov 2024 ($15.8M sold to 1 investors).
- Status: Privately Held (backing).
Who backs Conversio Health
4- ·Watch Conversio Health: the Monday email on marks, rounds and moves
Conversio Health funding rounds
2 roundsHow much has Conversio Health raised?
Conversio Health has raised $39 million in total; 2 of its rounds are on record. The largest on record was a $3.9 million seed round in Oct 2020; the most recent was a $20.3 million early-stage round in Jan 2024.
Conversio Health has filed 4 Form Ds with the SEC since 2020, most recently in Nov 2024 ($15.8 million sold to 1 investor).
Conversio Health investors
4 investors are on record for Conversio Health, including First Trust Capital Partners, HITLAB Innovators, Healthcare Growth Partners and Heritage Group (US). The early-stage round in Jan 2024 drew 1 investor.
About Conversio Health
Provider of pharmacotherapy management services intended to identify and overcome the challenges to optimal outcomes. The company's respiratory and chronic care management services are generally pharmacy-based models, which provide services that include targeted medical therapies as well as supplies and home delivery services, enabling patients with complex chronic respiratory conditions to get treated with unique medical drugs as per requirement.
- Sector
- Healthcare
- HQ
- San Luis Obispo, CA, United States
- Founded
- 2012
- Employees
- 53
- Website
- conversiohealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Conversio Health doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.